Omnicell Inc (OMCL) 32.76 $OMCL Omnicell Grows amid Weak

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Omnicell Inc (OMCL) 32.76 $OMCL

Omnicell Grows amid Weak Margins, Hospital Spending Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 8:57AM CDT
On Jun 1, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
MDSO: 45.12 (-0.40), DRAD: 5.17 (-0.12), OMCL: 32.76 (-0.45), ATHN: 128.88 (-1.08)

Omnicell (OMCL) Q1 Earnings Top Estimates, Margins Drag
Zacks Equity Research - Zacks Investment Research - Mon May 02, 10:05AM CDT
Omnicell, Inc. (OMCL) reported first-quarter 2016 adjusted earnings per share (EPS) of 30 cents, reflecting year-over-year improvement of 57.9%.
MDSO: 45.12 (-0.40), QSII: 11.74 (-0.19), CPSI: 38.00 (-0.56), OMCL: 32.76 (-0.45)

Deutsche Bank 41st Annual Health Care Conference
PR Newswire - Fri Apr 29, 7:07AM CDT
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for health care facilities, today announced they will present at the Deutsche Bank 41st annual Health Care Conference at the InterContinental Boston Hotel, Boston, MA.
DB: 17.68 (+0.81), OMCL: 32.76 (-0.45)

Omnicell reports 1Q loss
Automated Insights - Thu Apr 28, 4:47PM CDT
MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Thursday reported a first-quarter loss of $378,000, after reporting a profit in the same period a year earlier.
OMCL: 32.76 (-0.45)

UnityPoint Health® Selects Omnicell Medication Automation, Central Pharmacy and Analytics Solutions to Enhance Patient Safety and Efficiency
PR Newswire - Wed Apr 27, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL) today announced that UnityPoint Health® has awarded the Company a 10-year sole source contract as its provider of medication automation, central pharmacy automation and analytics software across 15 of its facilities. UnityPoint Health expects Omnicell's solutions to advance the highest standards of patient safety and security while optimizing pharmacist, nurse and anesthesiologist workflows. Two benefits offered by Omnicell are the Omnicell Unity enterprise platform, which gives health systems enhanced visibility across multiple Omnicell systems, and interoperability with the Epic electronic health record (EHR) system, which is used by UnityPoint Health. Installation is expected to be completed by the end of the year.
OMCL: 32.76 (-0.45)

Omnicell to Release First Quarter 2016 Earnings Results on April 28th
PR Newswire - Thu Apr 21, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, April 28, 2016, to discuss the Company's First Quarter 2016 financial results.
OMCL: 32.76 (-0.45)

UW Health Adds New IV Automation Capabilities and Solutions to Enhance Hybrid Drug Distribution Process
PR Newswire - Wed Apr 06, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL) is pleased to report that UW Health, the system associated with the University of Wisconsin-Madison, is adding the i.v.STATION ONCO(TM), which provides robotic sterile compounding of oncology admixtures, to their pharmacy automation solutions. UW Health selected the Aesynt product, now part of Omnicell's product portfolio, for use in the drug distribution process at their main University Hospital as well as in three additional facilities in their health system. In addition, the hospital is updating their existing ROBOT-Rx® automated medication dispensing robot and upgrading their AcuDose-Rx® automated dispensing cabinets. These and other products from Aesynt have recently been added to the Omnicell portfolio, expanding Omnicell's ability to support all key pharmacy distribution models, described as follows:
OMCL: 32.76 (-0.45)

Omnicell Announces New Guided Packing Software Designed to Increase Packing Accuracy of SureMed Multimed Blister Cards which Improve Patient Adherence
PR Newswire - Thu Mar 31, 10:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools to health care systems and pharmacies, today announced general availability of its latest medication adherence solution, the SureMed(TM) by Omnicell® Guided Packing software. This cloud-based software is designed to increase pharmacists' accuracy in filling SureMed multiple medication blister cards, which can improve medication adherence for patients on complex medication regimens. At launch, the software will interface with QS1, one of the most widely used pharmacy information systems (PIS), and is planned to integrate with additional systems later this year.
OMCL: 32.76 (-0.45)

Add Omnicell (OMCL) to Your Investment Portfolio: Here's Why
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 3:00PM CDT
On Mar 29, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
MDRX: 12.48 (-0.02), NVTA: 8.14 (-0.04), OMCL: 32.76 (-0.45), ATHN: 128.88 (-1.08)

Omnicell Announces Organizational Realignment to Increase Strategic and Operational Focus
PR Newswire - Mon Mar 21, 3:01PM CDT
Omnicell, Inc., (NASDAQ: OMCL), today announced it is realigning its organization to continue its growth strategy of offering differentiated products, expanding into new markets and increasing its presence through acquisitions. Over the past year, Omnicell has expanded its solutions and market reach through a series of acquisitions and new product announcements. The new organization will assure focus at the highest levels of the company on the successful integration of the acquisitions while simultaneously sustaining the momentum of new product innovation and expansion into new markets.
OMCL: 32.76 (-0.45)

Omnicell presents the pro forma financial information related to its acquisition of Aesynt
PR Newswire - Thu Mar 17, 3:15PM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today issued a press release presenting the pro forma financial information related to its recent acquisition of Aesynt Holding Coöperatief U.A. ("Aesynt".
OMCL: 32.76 (-0.45)

Omnicell Launches Pharmacy Locator to Connect Consumers with Pharmacies Supporting Medication Adherence Technology
PR Newswire - Wed Mar 16, 7:00AM CDT
Omnicell, Inc., (NASDAQ: OMCL), today announced the availability of the web-based Find-A-Pharmacy tool, which helps connect consumers and their families with pharmacists committed to improving the health of their patients through better medication adherence. By offering SureMed® by Omnicell® multiple medication adherence blister cards, pharmacists are helping patients greatly reduce the complexities of managing and taking multiple medications daily. Currently over one million people use SureMed to help successfully remain in compliance with physician-recommended therapy. The SureMed blister cards organize complex medication regimens by time of day and day of the week, making it easy for patients to know what to take and when.
OMCL: 32.76 (-0.45)

Omnicell: Sales, Acquisitions Impress; Margin Pressure Lingers
Zacks Equity Research - Zacks Investment Research - Fri Feb 19, 1:50PM CST
On Feb 17, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
ICUI: 104.98 (+0.28), INSY: 12.78 (+0.16), BAX: 44.94 (-0.07), OMCL: 32.76 (-0.45)

Voce Capital Nominates Air Methods Directors
BusinessWire - Fri Feb 19, 8:00AM CST
--Voce's Independent Nominees are Already Air Methods Shareholders, Tightening Board Alignment with Investors
AIRM: 36.03 (+0.14), EVHC: 26.58 (+0.02), INFU: 2.77 (-0.03), PRGX: 5.21 (-0.03), OMCL: 32.76 (-0.45)

Omnicell Q4 Earnings, Revenues Rise Y/Y; Aesynt Buyout Over
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 11:30AM CST
Omnicell's (OMCL) outperformance on the revenue front is encouraging. However, the company's performance on the bottom-line front remains mixed.
LMAT: 14.69 (+0.15), VASC: 38.97 (-0.48), OMCL: 32.76 (-0.45), HRC: 51.28 (+0.16)

athenahealth Crushes Q4 Earnings Estimate, Revenues Meet
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 10:30AM CST
athenahealth Inc. (ATHN) reported earnings of 45 cents per share in the fourth quarter of 2015, well ahead of the Zacks Consensus Estimate of 16 cents.
STRM: 1.24 (unch), CPSI: 38.00 (-0.56), OMCL: 32.76 (-0.45), ATHN: 128.88 (-1.08)

Omnicell tops Street 4Q forecasts
Automated Insights - Thu Feb 04, 3:59PM CST
MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Thursday reported fourth-quarter earnings of $7.7 million.
OMCL: 32.76 (-0.45)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic Bears Get New Tools, But Daily Risk Bites

Updated Category News Views 8

A $81.3 Billion Offering Invites Fast Money Anthropic arrived in public markets with the sort of numbers that make traders reach for both a calculator and a helmet. The company priced 980 million Class A shares at $83 on November 18, 2026, raising roughly $81.3 billion, then opened at $111.50 when it began Nasdaq trading on November 19. That is a monster debut by any...

Continue Reading
DKSH's Vietnam Oncology Pact Carries Real Promise, Risk

Updated Category News Views 5

A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 39

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 43

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading

Top 5 Most Recently Viewed Articles

Amicus Therapeutics Plans Third Quarter 2025 Earnings Call

Updated Category News Views 159

Amicus Therapeutics to Discuss Q3 2025 Financial Results Amicus Therapeutics (NASDAQ: FOLD) is preparing for an important financial discussion as it will host a conference call on November 4, 2025, at 8:30 a.m. ET. This call aims to provide insights into the company’s financial performance for the quarter ending September 30, 2025. Conference Call Participation...

Continue Reading
Cineplex Inc. Hits New Milestones In Q2 2025 Financials

Updated Category News Views 223

Cineplex Reports Impressive Growth in Second Quarter Financials Cineplex Inc. (TSX: CGX) has announced its financial performance for the second quarter of 2025, revealing remarkable growth across various metrics. The company’s total revenues surged to CAD 361.8 million, representing a robust 30.5% increase compared to the same period last year. This performance can be...

Continue Reading
Pinnacle Mergers & Acquisitions Finalizes $151M Deal with Dream Motor Group

Updated Category News Views 545

Pinnacle Mergers & Acquisitions Completes a Major Sale DALLAS — Pinnacle Mergers & Acquisitions, a premier automotive buy-sell advisory firm, has finalized the significant sale of Toyota of Montgomery and Lexus of Montgomery to the renowned Dream Motor Group, led by famed coach Nick Saban and automotive expert Joe Agresti. The deal is valued at an impressive $151...

Continue Reading
Atria Development Corporation Appoints New Vice President

Updated Category News Views 80

Atria Development Corporation Welcomes New Leadership Atria Development Corporation is thrilled to announce that Durval Terceira has been appointed as the new Vice President of Business Development and Labour Relations. With his impressive background, he brings a wealth of experience that is expected to steer the company towards its future goals. Durval Terceira: An...

Continue Reading
Ark Invest's Strategic Shift: Selling Block Inc. Shares

Updated Category News Views 289

Ark Invest Adjusts Its Strategy Cathie Wood's Ark Invest has recently made headlines by selling off a portion of its holdings in Block Inc. This decision, valued at an impressive $4.8 million, signifies a potential shift in investment strategy ahead of Block's forthcoming earnings report. Investors are closely monitoring this move as it coincides with Block's rising...

Continue Reading